A High-Throughput, Multi-Index Isothermal Amplification Platform for Rapid Detection of 19 Types of Common Respiratory Viruses Including SARS-CoV-2
Wanli Xing , Yingying Liu , Huili Wang , Shanglin Li , Yongping Lin , Lei Chen , Yan Zhao , Shuang Chao , Xiaolan Huang , Shaolin Ge , Tao Deng , Tian Zhao , Baolian Li , Hanbo Wang , Lei Wang , Yunpeng Song , Ronghua Jin , Jianxing He , Xiuying Zhao , Peng Liu , Weimin Li , Jing Cheng
Engineering ›› 2020, Vol. 6 ›› Issue (10) : 1130 -1140.
A High-Throughput, Multi-Index Isothermal Amplification Platform for Rapid Detection of 19 Types of Common Respiratory Viruses Including SARS-CoV-2
Fast and accurate diagnosis and the immediate isolation of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are regarded as the most effective measures to restrain the coronavirus disease 2019 (COVID-19) pandemic. Here, we present a high-throughput, multi-index nucleic acid isothermal amplification analyzer (RTisochipTM-W) employing a centrifugal microfluidic chip to detect 19 common respiratory viruses, including SARS-CoV-2, from 16 samples in a single run within 90 min. The limits of detection of all the viruses analyzed by the RTisochipTM-W system were equal to or less than 50 copies·μL−1, which is comparable to those of conventional reverse transcription polymerase chain reaction. We also demonstrate that the RTisochipTM-W system possesses the advantages of good repeatability, strong robustness, and high specificity. Finally, we analyzed 201 cases of preclinical samples, 14 cases of COVID-19-positive samples, 25 cases of clinically diagnosed samples, and 614 cases of clinical samples from patients or suspected patients with respiratory tract infections using the RTisochipTM-W system. The test results matched the referenced results well and reflected the epidemic characteristics of the respiratory infectious diseases. The coincidence rate of the RTisochipTM-W with the referenced kits was 98.15% for the detection of SARS-CoV-2. Based on these extensive trials, we believe that the RTisochipTM-W system provides a powerful platform for fighting the COVID-19 pandemic.
Coronavirus disease 2019 / Severe acute respiratory syndrome coronavirus 2 / Microfluidics / Nucleic acid testing / Isothermal
()
Supplementary files
/
| 〈 |
|
〉 |